Aaron Levitt

InvestorPlace Contributor

Aaron Levitt is an independent investment analyst and author living in State College, Pennsylvania. His work appears in several high profile publications in both print and on the web.

As an advocate for long-term globally oriented investing, Aaron believes that exchange traded funds have leveled playing field for Main Street. Following global macro-economic trends, investors now have several avenues to create great long term portfolios.

Aaron is a graduate of The Pennsylvania State University where he studied Economics and International Business. Aside for helping regular investors develop winning portfolios, his current projects include writing his first book on alternative energy investing.

Follow his picks and pans on Twitter at @AaronLevitt.

Recent Articles

5 Companies Making Giant Buybacks

By Aaron Levitt, InvestorPlace Contributor Aug 8, 2018

Buybacks are quickly becoming a hot topic on Wall Street, and with buyback activity surging, it's important to find the best companies that are doing them the right way.

5 Smart-Beta ETFs That Are Actually Making Intelligent Moves

By Aaron Levitt, InvestorPlace Contributor Aug 6, 2018

These smart-beta ETFs have been performing well in 2018 despite any volatility. Here's why investors should consider adding them to their portfolios.

3 Bond ETFs That Are Doing Much Better Than Bill Gross

By Aaron Levitt, InvestorPlace Contributor Aug 1, 2018

These three bond ETFs have a good shot at dethroning the Bond King, Bill Gross, as they have managed to outperform him lately. It might be time to make a switch.

Abiomed Has a Strong Long-Term Prognosis

By Aaron Levitt, InvestorPlace Contributor Jul 27, 2018

Abiomed is still killing it longer term. Sales are growing and the outlook for ABMD stock remains strong. The opportunity to buy the heart pump-maker is here.

Despite Delivering on Earnings, Halliburton Stock Is Still Not a Buy

By Aaron Levitt, InvestorPlace Contributor Jul 26, 2018

Halliburton had a great quarter, but it's still not a buy. A variety of big-time issues are affecting HAL stock.